High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment

被引:58
|
作者
Di Veroli, Giovanni Y. [1 ]
Davies, Mark R.
Zhang, Henggui
Abi-Gerges, Najah
Boyett, Mark R. [1 ]
机构
[1] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9NT, Lancs, England
关键词
computational modeling; human ether-a-go-go-related gene ion channel; drug-binding kinetics; QT prolongation; Torsades de Pointes arrhythmia; QT INTERVAL PROLONGATION; POTASSIUM CHANNEL; I-KR; VENTRICULAR ARRHYTHMIA; PROARRHYTHMIC RISK; ION CHANNELS; REPOLARIZATION; ELECTROPHYSIOLOGY; CISAPRIDE; BLOCK;
D O I
10.1152/ajpheart.00511.2012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Di Veroli GY, Davies MR, Zhang H, Abi-Gerges N, Boyett MR. High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment. Am J Physiol Heart Circ Physiol 304: H104-H117, 2013. First published October 26, 2012; doi:10.1152/ajpheart.00511.2012.-The use of computational models to predict drug-induced changes in the action potential (AP) is a promising approach to reduce drug safety attrition but requires a better representation of more complex drug-target interactions to improve the quantitative prediction. The blockade of the human ether-a-go-go-related gene (HERG) channel is a major concern for QT prolongation and Torsade de Pointes risk. We aim to develop quantitative in-silico AP predictions based on a new electrophysiological protocol (suitable for high-throughput HERG screening) and mathematical modeling of ionic currents. Electrophysiological recordings using the IonWorks device were made from HERG channels stably expressed in Chinese hamster ovary cells. A new protocol that delineates inhibition over time was applied to assess dofetilide, cisapride, and almokalant effects. Dynamic effects displayed distinct profiles for these drugs compared with concentration-effects curves. Binding kinetics to specific states were identified using a new HERG Markov model. The model was then modified to represent the canine rapid delayed rectifier K+ current at 37 degrees C and carry out AP predictions. Predictions were compared with a simpler model based on conductance reduction and were found to be much closer to experimental data. Improved sensitivity to concentration and pacing frequency variables was obtained when including binding kinetics. Our new electrophysiological protocol is suitable for high-throughput screening and is able to distinguish drug-binding kinetics. The association of this protocol with our modeling approach indicates that quantitative predictions of AP modulation can be obtained, which is a significant improvement compared with traditional conductance reduction methods.
引用
收藏
页码:H104 / H117
页数:14
相关论文
共 50 条
  • [21] A high-throughput drug screening strategy against coronaviruses
    Liu, Jia
    Li, Kang
    Cheng, Lin
    Shao, Jingjin
    Yang, Shukun
    Zhang, Wei
    Zhou, Guangqian
    Vries, Antoine A. F. de
    Yu, Zhiyi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 300 - 304
  • [22] Rational high-throughput screening in Preclinical Drug Metabolism
    Rodrigues, AD
    MEDICINAL CHEMISTRY RESEARCH, 1998, 8 (7-8) : 422 - 433
  • [23] High-throughput virtual screening for drug discovery in parallel
    Toledo-Sherman, LM
    Chen, DQ
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (03) : 414 - 421
  • [24] High-throughput screening technologies for drug glucuronidation profiling
    Trubetskoy, Olga
    Finel, Moshe
    Trubetskoy, Vladimir
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 (08) : 1061 - 1067
  • [25] High throughput screening of drug-protein binding in drug discovery
    Wan, Hong
    Bergstrom, Fredrik
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2007, 30 (5-8) : 681 - 700
  • [26] Hypothesis Testing in High-Throughput Screening for Drug Discovery
    Prummer, Michael
    JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (04) : 519 - 529
  • [27] High-throughput screening approaches to TB drug discovery
    Stanley, Sarah A.
    Grant, Sarah S.
    Barczak, Amy K.
    Hung, Deborah T.
    TUBERCULOSIS, 2013, 93 (01) : 110 - 110
  • [28] High-Throughput Drug Screening of Multicellular Tumor Spheroids
    Pardo, Ana Maria P.
    Gitschier, Hannah J.
    Randle, David H.
    Riss, Terry
    AMERICAN LABORATORY, 2016, 48 (08) : 8 - 11
  • [29] Protein Binding Pocket Optimization for Virtual High-Throughput Screening (vHTS) Drug Discovery
    Gazgalis, Dimitris
    Zaka, Mehreen
    Abbasi, Bilal Haider
    Logothetis, Diomedes E.
    Mezei, Mihaly
    Cui, Meng
    ACS OMEGA, 2020, 5 (24): : 14297 - 14307
  • [30] Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds
    Siqueira-Neto, Jair L.
    Song, Ok-Ryul
    Oh, Hyunrim
    Sohn, Jeong-Hun
    Yang, Gyongseon
    Nam, Jiyoun
    Jang, Jiyeon
    Cechetto, Jonathan
    Lee, Chang Bok
    Moon, Seunghyun
    Genovesio, Auguste
    Chatelain, Eric
    Christophe, Thierry
    Freitas-Junior, Lucio H.
    PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (05)